Antimicrobial Photodynamic Therapy in the Control of COVID-19

Antimicrobial photodynamic therapy (aPDT), using well known, safe and cost-effective photosensitizers, such as phenothiazines, e.g., methylene blue (MB), or porphyrins, e.g., protoporphyrin-IX (PP-IX), might help to mitigate the COVID-19 either to prevent infections or to develop photoactive fabrics...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Adelaide, Faustino, M. Amparo F., Neves, Maria G. P. M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344747/
https://www.ncbi.nlm.nih.gov/pubmed/32545171
http://dx.doi.org/10.3390/antibiotics9060320
_version_ 1783556016701440000
author Almeida, Adelaide
Faustino, M. Amparo F.
Neves, Maria G. P. M. S.
author_facet Almeida, Adelaide
Faustino, M. Amparo F.
Neves, Maria G. P. M. S.
author_sort Almeida, Adelaide
collection PubMed
description Antimicrobial photodynamic therapy (aPDT), using well known, safe and cost-effective photosensitizers, such as phenothiazines, e.g., methylene blue (MB), or porphyrins, e.g., protoporphyrin-IX (PP-IX), might help to mitigate the COVID-19 either to prevent infections or to develop photoactive fabrics (e.g., masks, suits, gloves) to disinfect surfaces, air and wastewater, under artificial light and/or natural sunlight.
format Online
Article
Text
id pubmed-7344747
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73447472020-07-09 Antimicrobial Photodynamic Therapy in the Control of COVID-19 Almeida, Adelaide Faustino, M. Amparo F. Neves, Maria G. P. M. S. Antibiotics (Basel) Opinion Antimicrobial photodynamic therapy (aPDT), using well known, safe and cost-effective photosensitizers, such as phenothiazines, e.g., methylene blue (MB), or porphyrins, e.g., protoporphyrin-IX (PP-IX), might help to mitigate the COVID-19 either to prevent infections or to develop photoactive fabrics (e.g., masks, suits, gloves) to disinfect surfaces, air and wastewater, under artificial light and/or natural sunlight. MDPI 2020-06-11 /pmc/articles/PMC7344747/ /pubmed/32545171 http://dx.doi.org/10.3390/antibiotics9060320 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Almeida, Adelaide
Faustino, M. Amparo F.
Neves, Maria G. P. M. S.
Antimicrobial Photodynamic Therapy in the Control of COVID-19
title Antimicrobial Photodynamic Therapy in the Control of COVID-19
title_full Antimicrobial Photodynamic Therapy in the Control of COVID-19
title_fullStr Antimicrobial Photodynamic Therapy in the Control of COVID-19
title_full_unstemmed Antimicrobial Photodynamic Therapy in the Control of COVID-19
title_short Antimicrobial Photodynamic Therapy in the Control of COVID-19
title_sort antimicrobial photodynamic therapy in the control of covid-19
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344747/
https://www.ncbi.nlm.nih.gov/pubmed/32545171
http://dx.doi.org/10.3390/antibiotics9060320
work_keys_str_mv AT almeidaadelaide antimicrobialphotodynamictherapyinthecontrolofcovid19
AT faustinomamparof antimicrobialphotodynamictherapyinthecontrolofcovid19
AT nevesmariagpms antimicrobialphotodynamictherapyinthecontrolofcovid19

Ejemplares similares